Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01032
Species: Homo sapiens
Position : chr6:37883250-37883831
Year: 2014
Title: Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants.
Genome Build: hg18
Enhancer Type: Enhancer
Condition: Disease
Disease Name: type 2 diabetes mellitus
PMID:  24413736
MONDO: MONDO:0005148
Tissue: islet of Langerhans
Tissue Ontology ID: UBERON:0000006
Cell Source: primary human pancreatic islets
Experiment Type: Enhancer activity assay; TF binding assay; Allele-specific functional assay; Genetic risk-variant analysis; Disease-variant functional analysis
High Throughput Method: PDX1 ChIP-seq; FOXA2 ChIP-seq; NKX2-2 ChIP-seq; NKX6-1 ChIP-seq; H3K4me1 ChIP-seq; H3K27ac ChIP-seq; FAIRE-seq; RNA-seq
Low Throughput Method: allele-specific luciferase reporter assay in MIN6 beta cells; EMSA; NEUROD1 supershift
About Target Gene
Target gene : ZFAND3
About TF
TF name : FOXA2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOXA2 FOXA1 transcription factor network pid 45
FOXA2 FOXA2 and FOXA3 transcription factor networks pid 45
FOXA2 Hedgehog signaling events mediated by Gli proteins pid 49
FOXA2 Regulation of gene expression in beta cells reactome 17
FOXA2 Maturity onset diabetes of the young kegg 25
FOXA2 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
FOXA2 Hs_Dopaminergic_Neurogenesis_WP2855_87239 wikipathways 19
FOXA2 Hs_Heart_Development_WP1591_90186 wikipathways 28
FOXA2 Hs_Ectoderm_Differentiation_WP2858_89329 wikipathways 56
Enhancer Associated Network
Overlapping Enhancers (hg18) 4 found
Enhancer ID Position Tissue Cell Disease
E_01033 chr6:37883250-37883831 islet of Langerhans NA type 2 diabetes mellitus
E_01034 chr6:37883250-37883831 islet of Langerhans NA type 2 diabetes mellitus
E_01035 chr6:37883250-37883831 islet of Langerhans NA type 2 diabetes mellitus
E_01036 chr6:37883250-37883831 islet of Langerhans NA type 2 diabetes mellitus
Expression of Target Genes for the Enhancer